Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wender

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|September 22, 2006
Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategyPaul A Wender, Joshua C Horan
Journal of the American Chemical Society|April 20, 2006
Rhodium(I)-catalyzed [4+2+2] cycloadditions of 1,3-dienes, alkenes, and alkynes for the synthesis of cyclooctadienesPaul A Wender, Justin P Christy
Synthesis|March 28, 2014
Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin AnaloguesPaul A Wender, Kelvin L Billingsley
Organic Letters|March 12, 2005
Identification of a tunable site in bryostatin analogs: C20 Bryologs through late stage diversificationPaul A Wender, Jeremy L Baryza
Organic Letters|February 9, 2007
Isolation, structure determination, and anti-cancer activity of apoptolidin DPaul A Wender, Kate E Longcore
Organic Letters|April 21, 2006
Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatinPaul A Wender, Vishal A Verma
Organic Letters|December 1, 2009
Apoptolidins E and F, new glycosylated macrolactones isolated from Nocardiopsis spPaul A Wender, Kate E Longcore
Organic Letters|July 1, 2005
Apoptolidins B and C: isolation, structure determination, and biological activityPaul A Wender, Martin Sukopp, Kate Longcore
Ophthalmic Surgery and Lasers|May 1, 1997
Corneal autograft patches for covering exposed transscleral suturesT Lifshitz, A Wender, R Lapid-Gortzak
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Organic Letters|July 1, 2008
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinityPaul A Wender, Vishal A Verma
Organic Letters|September 22, 2006
Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategyPaul A Wender, Joshua C Horan
Journal of the American Chemical Society|April 20, 2006
Rhodium(I)-catalyzed [4+2+2] cycloadditions of 1,3-dienes, alkenes, and alkynes for the synthesis of cyclooctadienesPaul A Wender, Justin P Christy
Synthesis|March 28, 2014
Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin AnaloguesPaul A Wender, Kelvin L Billingsley
Organic Letters|March 12, 2005
Identification of a tunable site in bryostatin analogs: C20 Bryologs through late stage diversificationPaul A Wender, Jeremy L Baryza
Organic Letters|February 9, 2007
Isolation, structure determination, and anti-cancer activity of apoptolidin DPaul A Wender, Kate E Longcore
Organic Letters|April 21, 2006
Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatinPaul A Wender, Vishal A Verma
Organic Letters|December 1, 2009
Apoptolidins E and F, new glycosylated macrolactones isolated from Nocardiopsis spPaul A Wender, Kate E Longcore
Organic Letters|July 1, 2005
Apoptolidins B and C: isolation, structure determination, and biological activityPaul A Wender, Martin Sukopp, Kate Longcore
Ophthalmic Surgery and Lasers|May 1, 1997
Corneal autograft patches for covering exposed transscleral suturesT Lifshitz, A Wender, R Lapid-Gortzak
Pageof 23